Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

"High prevalence of potential biases threatens the interpretation of trials ..."

Discussion in 'Other Health News and Research' started by Dolphin, Jun 14, 2011.

  1. Dolphin

    Dolphin Senior Member

    Messages:
    9,354
    Likes:
    22,381
    I haven't read this yet. Hopefully I will get to, eventually.

    Anyway, thought I'd highlight it. Again, it's probably going to be of "minority interest". I find these sorts of papers of interest to see what is seen as bad practice in ME/CFS/similar trials.

    Full free text: http://www.biomedcentral.com/content/pdf/1741-7015-9-73.pdf

     
  2. Enid

    Enid Senior Member

    Messages:
    3,309
    Likes:
    857
    UK
    Interesting Dolphin - haven't read yet - but the Conclusion is pretty much as one suspects.
     
  3. Nielk

    Nielk

    Messages:
    6,590
    Likes:
    9,509
    this is a trial to show that trials of chronic illnesses don't work?
    Does anyone else think this is humorous?
     
  4. Desdinova

    Desdinova Senior Member

    Messages:
    276
    Likes:
    133
    USA
    Wow! Reallllllllllly? To bad no one will really pay it much attention. Because studies have for the most part become 'a means to and end', A way to validate something regardless of flaws or validity and a way to cover or limit ones self from legal action.
     

See more popular forum discussions.

Share This Page